Phase 2 Renal Impairment Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Completed
Phase 2
Effects of chromium picolinate as an adjuvant on HbA1c levels in diabetic patients, and on eGFR and serum creatinine levels in diabetes induced renal impaired patients.
Diabetes Induced Renal ImpairmentDiabetes
Dr. Malik Hassan Mehmood140 enrolled1 locationACTRN12624000777594
Completed
Phase 2
Phase II study assessing the effect of carfilzomib treatment on early free light chain kinetics in myeloma patients with renal impairment
Multiple Myeloma with Renal Impairment
Australiasian Leukemia and Lymphoma Group40 enrolled5 locationsACTRN12614000301662
Recruiting
Phase 2
A Phase II trial of bortezomib and dexamethasone in renally-impaired patients with untreated multiple myeloma.
Untreated Multiple Myeloma patients with renal impairment.
Prof. Andrew Spencer28 enrolled1 locationACTRN12611000605998